DISHARMONY IN PATENT LAW: A COMPARATIVE STUDY OF PATENT ELIGIBILITY OF BIOLOGICAL SUBJECT MATTERS BETWEEN CHINA AND THE UNITED STATES.

This article compares the patent eligibility of biological subject matters in China and the United States. It discusses the different approaches taken by the two countries in areas such as methods for diagnosing and treating diseases, genetically modified animals and plants, genetic resources, and human stem cells. The article acknowledges the cultural and traditional influences on their respective patent systems and explores potential areas for harmonization to promote global intellectual property protection and innovation in biotechnology. It also discusses the impact of patent laws on the dissemination of knowledge and suggests the need for balancing cultural values and promoting innovation. [Extracted from the article]